They’re at different points of their careers, but Kyra Lesko and Lilia Calvert were equally effective Friday night.

Hex, the first unified, AI-powered workspace for data science and analytics, announced a $70 million Series C funding round today led by Avra, with participa ...

Accompanying the Tempest and Gemini into the world is a series of new fittings for the rest of the range, including various packs aptly called Beach Days, Road Trips, and Snow Days, but also new ...

Our Tempest Rising review breaks down what makes this sci-fi real-time strategy game interesting, in spite of its overly familiar structure.

The problem with Tempest Rising's multiplayer is that while it's perfectly competent at recreating a slice of the old Command & Conquer multiplayer with a pair of new and interesting factions, it ...

New for FC 25 Season 7, EA has introduced a second set of rewards accessible via the Premium Pass. It costs 1,000 FC Points, which is around £8.99 – although you can also get it for 500,000 in ...

At publishing time, HEX’s price is $0.002253; 24-hour transaction volumes barely top $250,000. HEX’s price spiked in 2021 before nearly falling off by early 2023. Source: CoinMarketCap ...

Tempest has a phase 3-ready PPARα antagonist, amezalpat, that it wants to study as a first-line treatment for hepatocellular carcinoma, the most common type of primary liver cancer. The biotech ...

Tempest Rising, a real-time strategy game that's being called a "s piritual successor " and an homage to Command & Conquer, is now available to everyone. It was supposed to be released on April 24 ...

Taken at face value, Tempest Rising could pass for a new Command and Conquer game, but while it stands on the shoulders of Westwood's greatest works, its mechanical subtleties, aesthetical quirks ...

Tempest Rising’s two good-sized single-player campaigns are a large helping of comfort food for RTS fans old enough to remember Command & Conquer in its heyday, and a way for everyone else to ...

Tempest, weathering stormy capital markets, hunts for partners for liver cancer drug By James Waldron Apr 10, 2025 7:24am Tempest Therapeutics Hepatocellular Carcinoma partnerships ...